lobbying_activities: 2191023

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2191023	972b33a7-e7ce-4adf-9ac2-64e43ebee295	Q3	BRAEBURN INC. FORMERLY KNOWN AS BRAEBURN PHARMACEUTICALS INC	401104621	BRAEBURN INC FORMERLY KNOWN AS BRAEBURN PHARMACEUTICALS INC	2018	third_quarter	INS	HR 5202 - Ensuring Patient Access to Substance Use Disorder Treatments Act of 2018 , S.916 - Protecting Patient Access to Emergency Medications Act of 2017: To amend the Controlled Substances Act to provide for the delivery of a controlled substance by a pharmacy to an administering practitioner. S.2680 - Opioid Crisis Response Act of 2018, H.R.5176 - Preventing Overdoses While in Emergency Rooms Act of 2018, H.R.6 - SUPPORT for Patients and Communities Act - all relevant sections pertaining to opioid crisis	HOUSE OF REPRESENTATIVES,SENATE		130000	0	0	2018-10-18T12:02:41.350000-04:00